CORRECTING and REPLACING LibertyStream Announces Closing of Second and Final Tranche of LIFE Offering
aTyr PharmaaTyr Pharma(US:LIFE) Businesswire·2025-12-16 23:02

Core Viewpoint - LibertyStream Infrastructure Partners Inc. has successfully closed the second and final tranche of its private placement offering, raising total gross proceeds of $9,999,999.10 through the issuance of 15,384,614 Units [1][4]. Group 1: Offering Details - The second tranche raised aggregate gross proceeds of $1,089,999.95 through the issuance of 1,676,923 Units at a price of $0.65 per Unit [1]. - Each Unit consists of one common share and one whole common share purchase warrant, with each Warrant allowing the purchase of one Common Share at an exercise price of $1.00 for a period of thirty-six months [2]. - The Offering was completed on a private placement basis under the "listed issuer financing" exemption, meaning the securities are not subject to a hold period under Canadian securities laws [3]. Group 2: Use of Proceeds - The net proceeds from the Offering will be utilized to develop the Company's direct lithium extraction technology, enhance lithium carbonate production, and provide product samples to potential customers [4]. Group 3: Company Overview - LibertyStream is focused on becoming one of North America's first commercial producers of lithium carbonate from oilfield brine, leveraging management's hydrocarbon experience to deploy proprietary technology [6][7].

aTyr Pharma-CORRECTING and REPLACING LibertyStream Announces Closing of Second and Final Tranche of LIFE Offering - Reportify